Picture of L&K Biomed Co logo

156100 L&K Biomed Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Annual cashflow statement for L&K Biomed Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsARSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-13,646-16,233-5,2399,151-16,792
Depreciation
Amortisation
Non-Cash Items3,5418,9616,229-6,47918,238
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-2,220-1,911-4,672-12,675-18,107
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-10,600-6,881-1,370-7,430-13,879
Capital Expenditures-459-107-2,099-615-3,131
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items5,760-2,395-4,315-8,38613,494
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities5,301-2,502-6,413-9,00110,363
Financing Cash Flow Items3,1210-56.9
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities16,3537335,62917,5691,658
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash11,197-8,713-2,348-1,212-657